Home

Neurotargeting Research Group

Main content

neurotargeting2024.png

The neurotargeting research group has a broad range of expertise. Advances in molecular neurobiology now provide possibilities for the development of new therapies designed for treatment of neurological and psychiatric disorders. This type of translational research requires competency in both basic molecular research and experience in practical treatment. 

The Neurotargeting Group constitutes one of three groups/labs in the Basic and Translational Neuroscience unit.

 

 

 

The group involves three principal investigators. Please visit their lab pages to learn more about their research.

 

Jan Haavik (Haavik lab)

Olga Therese Ousdal (Ousdal lab)

Emeritus Anni Vedeler (Vedeler lab)

Congratulations to Haya and Tyra!
Tyra & Haya

Master’s Thesis Defenses in Pharmacy

Congratulations to Haya and Tyra!

Finally published!
ACS_Baumann2024

Histone Deacetylase Inhibitors Show Selective Inhibition of Aromatic Amino Acid Hydroxylases

Aromatic amino acid hydroxylases (AAAHs) like PAH, TH, and TPH are essential for producing key neurotransmitters and require iron and tetrahydrobiopterin to function. This study screened 307 histone deacetylase inhibitors and found that compounds like panobinostat can inhibit AAAHs at low micromolar...

Best 3-min presentation!
 José Miguel Godoy Munoz_Biocat

Nanobodies in Protein Science and Beyond

Congratulation to José Miguel Godoy who won the prizes for best 3-min presentation at the Biocat conference last week.

News
A woman standing by a clock

Rare genotype identified causing early menopause

A recent GWAS meta-analysis identified a rare genetic variant in the CCDC201 gene that causes women to experience menopause 9 years earlier, significantly impacting their reproductive health and fertility.

PhD defence
Tor Ivar Phd defence

Can kynurenine be used as a biomarker for ADHD and depression?

Tore Ivar Malmei Aarsland will defend his PhD degree at the University of Bergen on 21 May 2024 with the thesis "Tryptophan and kynurenine pathway metabolites in neuropsychiatric disorders".